For the Inventor, By the Inventor

Enter assignee name

Boulder, CO, United States of America

Somatogen, Inc.

USPTO Granted Patents = 24

CIPO Patents = 1

Forward Citations = 336

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

David C Anderson (10 out of 45 patents)

Stephen J Hoffman (9 out of 11 patents)

Antony James Mathews (9 out of 17 patents)

4. Kiyoshi Nagai (8 out of 13 patents)

5. Gary L Stetler (8 out of 9 patents)

6. Douglas L Looker (7 out of 14 patents)

7. Michael Wagenbach (4 out of 4 patents)

8. Mary S Rosendahl (3 out of 18 patents)

9. Michael J Gerber (3 out of 21 patents)

10. Izydor Z Apostol (2 out of 5 patents)

11. Spencer J Anthony-Cahill (2 out of 4 patents)

12. Joseph D Levine (2 out of 3 patents)

13. Jacqueline F Aitken (2 out of 2 patents)

14. Julie A Lippincott (2 out of 2 patents)

15. Maura-Ann H Matthews (2 out of 3 patents)

24 patents: Sort by Forward Citations

1. 6274331 - Method of determining a functional linker for fusing globin subunts (2001-08-14),

2. 6242417 - Stabilized compositions containing hemoglobin (2001-06-05),

3. 6140071 - Proteins with mutations to decrease N-terminal methylation (2000-10-31),

4. 5844090 - Modified hemoglobin-like compounds (1998-12-01),

5. 5844089 - Genetically fused globin-like polypeptides having hemoglobin-like (1998-12-01),

6. 5844088 - Hemoglobin-like protein comprising genetically fused globin-like (1998-12-01),

7. 5811264 - Proteins with mutations to decrease N-terminal methylation (1998-09-22),

8. 5801019 - DNA encoding fused alpha-beta globin pseuodimer and production of (1998-09-01),

9. 5798227 - Co-expression of alpha and beta globins (1998-08-25),

10. 5776890 - Hemoglobins with intersubunit disulfide bonds (1998-07-07),

11. 5759517 - Hemoglobins as drug delivery agents (1998-06-02),

12. 5750132 - Treatment of adverse effects associated with administration of (1998-05-12),

13. 5744329 - DNA encoding fused di-beta globins and production of pseudotetrameric (1998-04-28),

14. 5739011 - DNA for the production of multimeric hemoglobins (1998-04-14),

15. 5717058 - Peptide inhibitors of tax-dependent transcription (1998-02-10),

Somatogen, Inc. is a biotechnology company focused on developing innovative therapies for rare genetic disorders. With a mission to improve patients' lives, we utilize advanced technologies and cutting-edge research to discover and develop novel treatments. Our expertise lies in gene therapy, gene editing, and protein engineering. By staying at the forefront of scientific advancements, we aim to address unmet medical needs and provide hope for individuals and families affected by rare genetic conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

24 Patents

#49 in Boulder, CO

#258 in Colorado

#13,436 in US

#25,875 in the World

Boulder, CO, United States of America

Somatogen, Inc.

Forward Citations = 336

25 inventors:

David C Anderson (10 out of 45 patents)

Stephen J Hoffman (9 out of 11 patents)

Antony James Mathews (9 out of 17 patents)

4. Kiyoshi Nagai (8 out of 13 patents)

5. Gary L Stetler (8 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…